Hep Email Update
Rapid Vaccine Rollout Prevented a Hepatitis A Outbreak at LA County Jail
The county’s Correctional Health Services department offered hepatitis A vaccination to more than 2,700 incarcerated individuals at risk.
UNAIDS Urges Scaling Up of Evidence-Based Services to Address the Transmission of HIV and Viral Hepatitis Among People Who Use Drugs
Only 1% of people who inject drugs have access to recommended harm reduction services.
When Co-Pay Assistance Backfires on Patients
Nineteen states limit copay accumulator programs, and patient advocacy groups have won a favorable court ruling against the programs.
Advertisement
FDA Approves First-Ever Drug for Fatty Liver Disease
People who used resmetirom (Rezdiffra) in a late-stage clinical trial experienced both MASH resolution and fibrosis improvement.
What Is Fatty Liver Disease? (MASLD and MASH)
Learn the latest about fatty liver.
What Is Hepatitis C?
Get the basics!
Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2024 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.